ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Preserve NCI’s Role In Applied Research And Its Unique Environment, Chabner Says

May 12, 1995

Symptoms Don’t Help Detect Early-Stage Ovarian Cancer

February 26, 2010

Breast Cancer Family History Doesn’t Increase Risk Of Ovarian Cancer, Study Says

September 30, 2005

In Brief: Administration Backs Down On a Attempt To Kill General Research Support, Will Try To Modify It

November 1, 1974

Panel Explores Barriers In Access To Cancer Care.

February 2, 2001

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011